1-119915647-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024408.4(NOTCH2):​c.7075C>G​(p.Pro2359Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00596 in 1,614,064 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P2359P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0047 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0061 ( 40 hom. )

Consequence

NOTCH2
NM_024408.4 missense

Scores

1
18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 1.34

Publications

28 publications found
Variant links:
Genes affected
NOTCH2 (HGNC:7882): (notch receptor 2) This gene encodes a member of the Notch family. Members of this Type 1 transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway which regulates interactions between physically adjacent cells. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signaling pathway that plays a key role in development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remain to be determined. This protein is cleaved in the trans-Golgi network, and presented on the cell surface as a heterodimer. This protein functions as a receptor for membrane bound ligands, and may play a role in vascular, renal and hepatic development. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NOTCH2 Gene-Disease associations (from GenCC):
  • acroosteolysis dominant type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome due to a NOTCH2 point mutation
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Alagille syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006585866).
BP6
Variant 1-119915647-G-C is Benign according to our data. Variant chr1-119915647-G-C is described in ClinVar as Benign. ClinVar VariationId is 134983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00469 (715/152350) while in subpopulation NFE AF = 0.00675 (459/68034). AF 95% confidence interval is 0.00624. There are 2 homozygotes in GnomAd4. There are 332 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 715 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH2NM_024408.4 linkc.7075C>G p.Pro2359Ala missense_variant Exon 34 of 34 ENST00000256646.7 NP_077719.2 Q04721Q6IQ50Q9UFD5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH2ENST00000256646.7 linkc.7075C>G p.Pro2359Ala missense_variant Exon 34 of 34 1 NM_024408.4 ENSP00000256646.2 Q04721

Frequencies

GnomAD3 genomes
AF:
0.00470
AC:
715
AN:
152232
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00582
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00800
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00675
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.00457
AC:
1148
AN:
251234
AF XY:
0.00432
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00390
Gnomad ASJ exome
AF:
0.000497
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00818
Gnomad NFE exome
AF:
0.00660
Gnomad OTH exome
AF:
0.00554
GnomAD4 exome
AF:
0.00609
AC:
8902
AN:
1461714
Hom.:
40
Cov.:
32
AF XY:
0.00574
AC XY:
4174
AN XY:
727144
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33480
American (AMR)
AF:
0.00427
AC:
191
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.000459
AC:
12
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000846
AC:
73
AN:
86246
European-Finnish (FIN)
AF:
0.00876
AC:
467
AN:
53296
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00696
AC:
7742
AN:
1111984
Other (OTH)
AF:
0.00651
AC:
393
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
570
1139
1709
2278
2848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00469
AC:
715
AN:
152350
Hom.:
2
Cov.:
33
AF XY:
0.00446
AC XY:
332
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.00159
AC:
66
AN:
41572
American (AMR)
AF:
0.00581
AC:
89
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.00800
AC:
85
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00675
AC:
459
AN:
68034
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00571
Hom.:
5
Bravo
AF:
0.00472
TwinsUK
AF:
0.00755
AC:
28
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00349
AC:
30
ExAC
AF:
0.00451
AC:
548
EpiCase
AF:
0.00611
EpiControl
AF:
0.00599

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 24, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30304577, 24728327, 18508802) -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NOTCH2: BP4, BS1, BS2 -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:3Other:1
Jan 05, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Hajdu-Cheney syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
15
DANN
Benign
0.59
DEOGEN2
Benign
0.31
T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.37
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.84
T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.0066
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.69
N
PhyloP100
1.3
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.15
Sift
Benign
0.15
T
Sift4G
Benign
0.24
T
Polyphen
0.0020
B
Vest4
0.10
MVP
0.63
MPC
0.14
ClinPred
0.0032
T
GERP RS
3.5
Varity_R
0.033
gMVP
0.37
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75831573; hg19: chr1-120458270; API